Article Details

Arbutus BioPharma Corp (NASDAQ:ABUS) Additional Phase 1a/1b AB-729 Study Data Shows ...

Retrieved on: 2021-02-11 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Arbutus BioPharma Corp (NASDAQ:ABUS) Additional Phase 1a/1b AB-729 Study Data Shows .... View article details on hiswai:

Excerpt

Arbutus BioPharma Corp (NASDAQ:ABUS) has announced additional results from the on-going Phase 1a/1b clinical study with AB-729, the ...

Article found on: biopharmajournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo